wiki.sine.space | sinespace

The part of microglial cells. Prog Neurobiol 2008, 84:211?33. Cherry JD, Olschowka JA

From wiki.sine.space
Jump to: navigation, search

Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF: CB2 receptor Is necessary to re-establish metabolic support [38. VEGF is upregulated during a lot of] activation attenuates microcirculatory dysfunction through cerebral ischemic/reperfusion injury. Cherry JD, Olschowka JA, O'Banion MK: Neuroinflammation and M2 microglia: the superior, the poor, and also the inflamed. J Neuroinflammation 2014, 11:98. Turtzo LC, Lescher J, Janes L, Dean DD, Budde MD, Frank JA: Macrophagic and microglial responses immediately after focal traumatic brain injury inside the female rat. J Neuroinflammation 2014, 11:82. Cabral GA, Griffin-Thomas L: Emerging function on the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Specialist Rev Mol Med 2009, 11:e3. Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F: CB2 receptors in the brain: part in central immune function. Br J Pharmacol 2008, 153:240?51. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M, Zimmer A: Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(two) receptor. Eur J Pharmacol 2000, 396:141?49. Fraga D, Raborn ES, Ferreira GA, Cabral GA: Cannabinoids inhibit migration of microglial-like cells towards the HIV PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28499442 protein Tat. J Neuroimmune Pharmacol 2011, 6:566?77. Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61?5. Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, Sagredo O, Benito C, Romero J, Azcoitia I, Fern dez-Ruiz J, Guzm M, Galve-Roperh I: Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's illness excitotoxicity. Brain 2009, 132:3152?164. Elliott MB, Tuma RF, Amenta PS, Barbe MF, Jallo JI: Acute effects of a selective cannabinoid-2 receptor agonist on PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27689333 neuroinflammation in a model of traumatic brain injury. J Neurotrauma 2011, 28:973?81. Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF: CB2 receptor activation attenuates microcirculatory dysfunction throughout cerebral ischemic/reperfusion injury. Microvasc Res 2009, 78:86?4. Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF: Cannabinoid CB(two) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab 2007, 27:1387?396. Adhikary S, Li H, Heller J, Skarica M, Zhang M, Ganea D, Tuma RF: Modulation of inflammatory responses by a cannabinoid-2-selective agonist following spinal cord injury. J Neurotrauma 2011, 28:2417?427. Amenta PS, Jallo JI, Tuma RF, Elliott MB: A cannabinoid variety 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res 2012, 90:2293?2305. Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, Garcia-Gutierrez MS, Vivancos J, Nombela F, Torres M, Burguete MC, Manzanares J, Lizasoain I, Moro MA: Cannabinoid variety 2 receptor activation downregulates stroke-induced classic and option brain macrophage/microglial activation concomitant to neuroprotection. Stroke 2012, 43:211?19. Price tag DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, Robust R, Lutz B, Marsicano G, Roberts JL, Giuffrida A: WIN55,212-2, a cannabinoidAmenta et al. Journal of Neuroinflammation 2014, 11:191 http://www.jneuroinflammation.com/content/11/1/Page 10 of26.27.28.29. 30.31. 32.33.34.35.36.